Skip to content Skip to sidebar Skip to footer

Blog

Retatrutide and Appetite Suppression Research: GIP, GLP-1, Glucagon Receptor Biology and Satiety Mechanisms UK 2026

All content on this page is for research and educational purposes only. Retatrutide is a research compound supplied for laboratory use. It is not approved for human therapeutic use in the UK and is not intended to diagnose, treat, cure or prevent any condition.Introduction: Triple Agonism and the Appetite Regulation FrontierAppetite regulation is…

Read More

Melanotan 2 and Photoprotection Research: Melanogenesis, UV Biology and Skin Cancer Prevention UK 2026

Melanotan 2 and Photoprotection Research: Melanogenesis, UV Biology and Skin Cancer PreventionMelanotan II (MT-II) — the cyclic heptapeptide melanocortin receptor agonist — is most commonly discussed in research contexts for its effects on sexual function and pigmentation. Less examined but mechanistically important is Melanotan II's photoprotective biology: the mechanisms through which stimulated melanogenesis affects…

Read More

BPC-157 and Liver Research: Hepatoprotection, Fibrosis Biology and Alcohol-Induced Damage UK 2026

BPC-157 and Liver Research: Hepatoprotection, Fibrosis Biology and Alcohol-Induced DamageBPC-157 (Body Protection Compound 157) has earned its name from a remarkably broad tissue protection profile across multiple organ systems. Among its most compelling and extensively studied applications is hepatoprotection — the protection of liver tissue from toxic, ischaemic, and inflammatory injury. The liver is…

Read More

Sermorelin and Longevity Research: GH Axis, Somatopause and Ageing Biology UK 2026

Sermorelin and Longevity Research: GH Axis, Somatopause and Ageing BiologySermorelin (GHRH 1-29 NH₂) — the synthetic form of the first 29 amino acids of endogenous growth hormone releasing hormone — is the foundational GHRH analogue in research, predating CJC-1295 and other longer-acting GHRH variants. Its relatively short plasma half-life (approximately 10–20 minutes) and once-daily…

Read More

Ipamorelin and Body Composition Research: Fat Loss, Lean Mass and Metabolic Biology UK 2026

Ipamorelin and Body Composition Research: Fat Loss, Lean Mass and Metabolic BiologyIpamorelin — a selective GHS-R1a agonist pentapeptide — is distinguished from other growth hormone releasing peptides by its exceptional selectivity: it stimulates GH release from pituitary somatotrophs with minimal effects on cortisol, prolactin, or ACTH secretion. This clean pharmacological profile makes it an…

Read More

GHK-Cu and Skin Ageing Research: Photoageing, Collagen Remodelling and Senescent Cell Biology UK 2026

GHK-Cu and Skin Ageing Research: Photoageing, Collagen Remodelling and Senescent Cell BiologyGHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has one of the broadest research profiles of any peptide in the skin biology literature — spanning wound healing acceleration, collagen and elastin synthesis, anti-inflammatory action, and antioxidant gene upregulation. In the specific context of skin ageing research, GHK-Cu's…

Read More

Selank and Cognitive Enhancement Research: Memory, Learning and Neuroplasticity Biology UK 2026

Selank and Cognitive Enhancement Research: Memory, Learning and Neuroplasticity BiologySelank (Tuftsin-Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic analogue of the endogenous tetrapeptide Tuftsin, extended with a Pro-Gly-Pro C-terminal sequence that confers stability against plasma proteases. While Selank's anxiolytic properties — mediated through GABA-A modulation, serotonin enhancement, and HPA axis normalisation — form the primary focus of its…

Read More

CJC-1295 and Bone Density Research: GH Axis, IGF-1 and Osteoporosis Biology UK 2026

CJC-1295 and Bone Density Research: GH Axis, IGF-1 and Osteoporosis BiologyCJC-1295 — the GHRH analogue that achieves prolonged GH axis stimulation through its Drug Affinity Complex (DAC) technology or shorter-acting non-DAC form — has an established preclinical and early clinical profile primarily focused on body composition, GH pulsatility, and IGF-1 modulation. A less prominently…

Read More

IGF-1 LR3 and Cancer Research: Tumour Biology, Proliferative Signalling and IGF Axis in Oncology UK 2026

IGF-1 LR3 and Cancer Research: Tumour Biology, Proliferative Signalling and IGF Axis in OncologyThe insulin-like growth factor 1 (IGF-1) axis is among the most extensively studied signalling pathways in cancer biology. IGF-1 receptor (IGF-1R) activation promotes tumour cell survival, proliferation, invasion, and resistance to both chemotherapy and targeted therapy — making it a widely…

Read More

Hexarelin and Growth Hormone Deficiency Research: GHS-R1a, Pituitary Reserve Testing and GHD Biology UK 2026

Hexarelin and Growth Hormone Deficiency Research: GHS-R1a, Pituitary Reserve Testing and GHD BiologyHexarelin (Examorelin) — a synthetic hexapeptide GH secretagogue with the sequence His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH₂ — is among the most potent GHS-R1a (growth hormone secretagogue receptor 1a) agonists characterised in the GH releasing peptide family. Its potency exceeds that of GHRP-2, GHRP-6, and ipamorelin in…

Read More

99% Purity Guarantee
Trusted By Researchers
★★★★★
Celebrating 500,000 Orders
Third party verified